New York, NY, August 04, 2012 --(PR.com
)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Michael A. Walsh, Partner, Strasburger & Price, LLP will speak at the Knowledge Congress’ webcast entitled: “Understanding the Food and Drug Administration’s Guidance on Direct-To-Consumer Television Advertisements.” This event is scheduled for Thursday, January 31, 2013 from 12:00pm – 2:00pm (ET).
For further details, please visit:
About Michael Walsh
Michael Walsh is a partner in the Dallas office of Strasburger & Price and leads the firm’s Drug and Device Industry Team. He devotes most of his practice to representing clients in FDA regulated industries on issues related to labeling and compliance and is a frequent speaker on issues concerning FDA labeling and marketing. Mike is also a member of the Laws and Regulations Committee of the Association of Food and Drug Officials and DRI Drug and Device Committee.
About Strasburger & Price, LLP
Strasburger & Price, LLP is an AmLaw 250 law firm offering clients a broad range of legal services in over 30 practice areas. The firm represents international, national and middle market Texas-based companies with the goal of finding effective business solutions while complying with the highest standards of character, professionalism and understanding. To learn more Strasburger's rich history, diverse areas of practice and experienced attorneys, visit www.strasburger.com.
The Food and Drug Administration recently issued draft guidance to explain its approach to pre-dissemination review of direct-to-consumer (DTC) television advertisements. The draft guidance represents a significant change in FDA’s approach and attempts to provide detail on what steps advertisers should take and what enforcement steps, including civil and criminal penalties, may be expected.. If adopted, the Guidance will present significant compliance challenges for all companies in the industry.
Pharmaceutical companies and ad sponsors should have a complete understanding of FDA’s current thinking as reflected in this draft guidance to assess its potential impact on their business relations.
The Knowledge Group is assembling a panel of distinguished professionals and key regulators to help understand the complex issues related to the draft guidance and its impact on your firm and the broader market. The speakers will present their expert opinions in a two-hour live Webcast.
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: www.knowledgecongress.org